QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Host Investor Webinar on Feb. 5
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company advancing targeted antitumor virotherapies, will host an investor webinar on Feb. 5, 2025, at 4:15 p.m. ET. The event, organized by RedChip Companies, will feature CFO Andrew Jackson and CSO Antonio F. Santidrian, PharmD, PhD, discussing Calidi’s cell-based delivery platforms designed to enhance oncolytic virus-based cancer treatments. Topics will include the company’s lead programs, such as CLD-400 for metastatic cancers, CLD-201 for advanced solid tumors, and CLD-101 for high-grade glioma. A live Q&A session will follow. To view the full press release, visit: https://ibn.fm/R3jSL About Calidi Biotherapeutics Calidi Biotherapeutics specializes in…